Repligen Corp (NASDAQ:RGEN)

32.09
Delayed Data
As of Apr 17
 -0.21 / -0.65%
Today’s Change
14.92
Today|||52-Week Range
34.15
+62.07%
Year-to-Date

Today’s Trading

Previous close32.30
Today’s open32.04
Day’s range31.68 - 32.40
Volume333,984
Average volume (3 months)379,360
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)+17.33%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-6.78%
P/E ratio130.6
Price/Sales10.13
Price/Book9.41

Competitors

 Today’s
change
Today’s
% change
ALDRAlder Biopharmaceuti...-0.09-0.35%
ARRYArray Biopharma Inc-0.31-4.07%
ZSPHZS Pharma Inc-1.62-3.84%
PRTAProthena Corporation...-1.55-4.13%
Data as of 4:00pm ET, 04/17/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)$0.07
Annual revenue (last year)$63.5M
Annual profit (last year)$8.2M
Net profit margin12.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Treasurer, Director &
CAO
Walter C. Herlihy
Chief Operating Officer &
Director
Tony J. Hunt
Corporate headquarters
Waltham, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers